Table 1 Characteristics of overall participants and participants in each quartile group for urate
| 1st quartile Urate: 0.3–5.1 mg/dl | 2nd quartile Urate: 5.2–5.9 mg/dl | 3rd quartile Urate: 6.0–6.7 mg/dl | 4th quartile Urate: 6.8–12.9 mg/dl | Overall Urate: 0.3–12.9 mg/dl | |
|---|---|---|---|---|---|
| Number | 3150 | 3214 | 2986 | 3178 | 12,528 |
| Urate (mg/dl) | 4.38 ± 0.68 | 5.56 ± 0.23** | 6.33 ± 0.22** | 7.59 ± 0.76** | 5.96 ± 1.29 |
| Age (years) | 48.3 ± 9.5 | 47.1 ± 9.6** | 46.4 ± 9.3** | 46.6 ± 9.2** | 47.1 ± 9.4 |
| Smokers (%) | 57.7 | 57.7 | 53.5** | 53.5** | 55.6 |
| Drinkers (%) | |||||
| Occasional | 35.1 | 34.3 | 35.5 | 33.2 | 34.5 |
| Regular | 38.9 | 43.1** | 46.8** | 52.9** | 45.4 |
| Regular exercise (%) | 11.0 | 11.5 | 10.9 | 12.0 | 11.4 |
| Height (cm) | 169.3 ± 6.4 | 169.9 ± 6.1** | 170.2 ± 6.2** | 170.2 ± 6.1** | 169.9 ± 6.2 |
| Body weight (kg) | 64.6 ± 10.1 | 66.8 ± 9.9** | 68.8 ± 10.3** | 71.4 ± 11.5** | 67.9 ± 10.8 |
| Waist circumference (cm) | 80.4 ± 8.7 | 82.1 ± 8.6** | 83.8 ± 8.3** | 86.3 ± 8.9** | 83.1 ± 8.9 |
| BMI (kg/m2) | 22.5 ± 3.1 | 23.1 ± 3.1** | 23.7 ± 3.1** | 24.6 ± 3.5** | 23.5 ± 3.3 |
| Triglycerides (mg/dl) | 90 (62, 130) | 95 (66, 141) | 107 (73, 162) | 130 (86, 204) | 104 (70, 158) |
| Therapy for hypertension (%) | 10.0 | 10.5 | 12.1** | 15.1** | 11.9 |
| Therapy for dyslipidemia (%) | 4.3 | 4.7 | 4.8 | 5.0 | 4.7 |
| Therapy for diabetes (%) | 5.2 | 4.4 | 3.4** | 2.6** | 3.9 |
| High WHtR (%) | 30.2 | 35.7** | 43.1** | 54.7** | 40.9 |
| Hypertension (%) | 23.3 | 24.5 | 29.4** | 38.4** | 28.9 |
| Hyper-triglyceridemia (%) | 18.8 | 21.8** | 29.5** | 41.9** | 28.0 |
| Hypo-HDL cholesterolemia (%) | 6.5 | 9.0** | 10.0** | 12.0** | 9.3 |
| Dyslipidemia (%) | 24.4 | 28.6** | 35.5** | 46.9** | 33.8 |
| Diabetes (%) | 8.9 | 6.8** | 5.4** | 4.5** | 6.4 |
| Metabolic syndrome (%) | 8.4 | 8.9 | 10.7** | 16.1** | 11.0 |